Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
How Does a Methylation Panel Guide Nutrient Therapy
These LCACs enhance the ability of RAW264.7 cells to phagocytose lipids by upregulating macrophage receptor with collagenous structure (MARCO), thereby aggravating the accumulation of intracellular lipids, which promotes the formation of foam cells and accelerates the development of atherosclerosis [228]
Patients recovering from surgeries, especially those involving the digestive tract, should closely monitor their B12 levels
Glutathione IV Push At PointInfusion Defend Your Skin & Body from the Inside Out Our Glutathione IV Push delivers a concentrated, high dose of this powerful antioxidant straight into your bloodstream, ensuring maximum absorption and effectiveness
US$ 29.17
US$ 20.45
US$ 21.52
US$ 28.62
US$ 26.72
US$ 21.64
US$ 20.83
US$ 27.22
US$ 24.78
US$ 23.57
US$ 27.18
